177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, cutaneous melanoma, endometrium neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, head and neck squamous cell carcinoma, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, mismatch repair cancer syndrome 1, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, small cell lung carcinoma, squamous cell carcinoma, triple-negative breast carcinoma, uterine disorder	Recruiting	Early phase 1	2026-02-19		NCT06305962

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Radiopharm Theranostics, Ltd	7

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cancer Research SA (CRSA)	Adelaide	Australia	3
GenesisCare Murdoch	Murdoch	Australia	3
Gold Coast University Hospital	Southport	Australia	35
Nepean Hospital	Kingswood	Australia	26
Wollongong Hospital	Wollongong	Australia	29